Prolife Groups Press Opposition to Upjohn’s Abortion Drugs

Prolife activists are stepping up their campaign against the Upjohn Company’s production of prostaglandin drugs used in abortions.

Upjohn is the only American manufacturer of prostaglandins used in second-trimester abortions. The pharmaceutical company also is a leading international supplier of the drugs. According to the Centers for Disease Control, prostaglandins are used in some 10,000 abortions each year during the middle months of pregnancy.

A nationwide boycott of Upjohn products, including Nuprin, Motrin, and Unicap vitamins, has been in effect for more than a year. To promote the boycott and call attention to Upjohn’s continued production of prostaglandins, 15 prolife organizations recently sponsored a rally at Upjohn’s headquarters in Kalamazoo, Michigan. The rally attracted some 1,000 demonstrators.

“Hopefully, the people in the community had their consciences pricked and will be able to effect change within the company,” said Constance Anders, president of Kalamazoo Right to Life. Upjohn is the largest employer in the Kalamazoo area.

As the Kalamazoo rally was taking place, the Christian Action Council sponsored smaller protests at 14 of Upjohn’s 21 regional offices across the country. Curt Young, executive director of the Christian Action Council, said his organization wants Upjohn to realize the boycott has national support. In a related effort, several stockholders attending Upjohn’s recent stockholders’ meeting asked the company to stop producing abortion drugs.

The National Right to Life Committee and other prolife groups say the protest has assumed a greater urgency because Upjohn is researching a new drug called Meteneprost. The drug is a prostaglandin-tipped suppository that could induce an abortion in the first months of pregnancy.

The Upjohn company says it plans to continue producing prostaglandins, emphasizing the drugs have been approved by the federal Food and Drug Administration. According to a company publication, “Upjohn naturally recognizes the subject as controversial, but it has proceeded … for reasons of scientific obligation; belief in basic rights of choice for individuals, physicians, and society in general; and competitive thrust in research, discovery and development.” The publication also noted that despite “varying levels of disapproval by some anti-abortion groups,” Upjohn has backed the production of prostaglandins for more than 12 years.

By Kim A. Lawton.

Our Latest

Review

Safety Shouldn’t Come First

A theologian questions our habit of elevating this goal above all others.

What Would Lecrae Do?

Why Kendrick Lamar’s question matters.

No More Sundays on the Couch

COVID got us used to staying home. But it’s the work of God’s people to lift up the name of Christ and receive God’s Word—together.

Public Theology Project

A Hurricane Doesn’t Tell Us Who to Hate

What natural disasters reveal about God and neighbor.

The Russell Moore Show

Belief, Experience, and Expectations of God

Steve Cuss talks about finding peace in the tensions of our faith.

Review

The Bible Contains Discrepancies. That Doesn’t Make It Untrustworthy.

Scholar Michael Licona makes the case for a “flexible inerrancy.”

News

The Gettys’ Modern Hymn Movement Has Theological Pull

Yet even at their annual worship conference, there’s room for multiple styles of music to declare the stories of the Bible.

Be Afraid

Be Afraid Bonus Episode 2: Mac Brandt

Mac Brandt discusses horror, race, and playing the bad guy.

Apple PodcastsDown ArrowDown ArrowDown Arrowarrow_left_altLeft ArrowLeft ArrowRight ArrowRight ArrowRight Arrowarrow_up_altUp ArrowUp ArrowAvailable at Amazoncaret-downCloseCloseEmailEmailExpandExpandExternalExternalFacebookfacebook-squareGiftGiftGooglegoogleGoogle KeephamburgerInstagraminstagram-squareLinkLinklinkedin-squareListenListenListenChristianity TodayCT Creative Studio Logologo_orgMegaphoneMenuMenupausePinterestPlayPlayPocketPodcastRSSRSSSaveSaveSaveSearchSearchsearchSpotifyStitcherTelegramTable of ContentsTable of Contentstwitter-squareWhatsAppXYouTubeYouTube